
Full OptIMMize-1 results show high skin clearance rates with risankizumab in children and teens with psoriasis, sustained through 52 weeks.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a study published in Pediatrics. The study looked at whether adolescents who engage in the nonmedical use of opioid medications are more likely to engage in risky sexual behaviors.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a study published in Pediatrics. The study looked at whether adolescents who engage in the nonmedical use of opioid medications are more likely to engage in risky sexual behaviors.






